n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with butaprost in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elvin, JA; Matzuk, MM; Yan, C | 1 |
| Brune, K; Hinz, B; Pahl, A | 1 |
| Akaike, A; Banno, Y; Fushimi, K; Nakashima, S; Shimizu, K; Takigawa, M | 1 |
| Breyer, RM; Chen, C; Yang, H; Zhang, J | 1 |
4 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and butaprost
| Article | Year |
|---|---|
Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway.
Topics: Alprostadil; Animals; Bone Morphogenetic Protein 15; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Female; Granulosa Cells; Growth Differentiation Factor 9; Growth Substances; Indomethacin; Intercellular Signaling Peptides and Proteins; Isoenzymes; Kinetics; Male; Mice; Mice, Inbred ICR; Models, Biological; Nitrobenzenes; Progesterone; Prostaglandin-Endoperoxide Synthases; Prostaglandins E, Synthetic; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Transcription, Genetic | 2000 |
Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Bucladesine; Cells, Cultured; Cyclic AMP; Cyclooxygenase 1; Cyclooxygenase 2; Dexamethasone; Dinoprostone; Flurbiprofen; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Lipopolysaccharides; Membrane Proteins; Monocytes; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Transcription, Genetic | 2000 |
Implication of prostaglandin E(2) in TNF-alpha-induced release of m-calpain from HCS-2/8 chondrocytes. Inhibition of m-calpain release by NSAIDs.
Topics: Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Calpain; Cell Line, Tumor; Chondrocytes; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Diclofenac; Dinoprostone; Humans; Nitrobenzenes; Phenylpropionates; Prostaglandin Antagonists; Sulfonamides; Tumor Necrosis Factor-alpha; Up-Regulation; Xanthones | 2004 |
Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor.
Topics: Alprostadil; Animals; Animals, Newborn; Colforsin; Cyclooxygenase Inhibitors; Dinoprostone; Electric Stimulation; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Maze Learning; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neurons; Nitrobenzenes; Patch-Clamp Techniques; Physical Phenomena; Reaction Time; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Sulfonamides; Synapses; Time Factors | 2009 |